Late-breaking positive Phase III data from ianalumab NEPTUNUS-1 and NEPTUNUS-2 trials in Sjögren’s disease to be presented Biomarker data informing use of investigational CAR-T cell therapy ...
Add articles to your saved list and come back to them any time. After going commercial in August and September with two medical diagnostic products, Proteomics International is now set to see a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback